GSK as of June 30, 2026
Portfolio Holdings for GSK
GSK holds 13 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics Namen Akt (CRSP) | 29.2 | $176M | 3.2M | 54.54 | |
| Wave Life Sciences SHS (WVE) | 17.6 | $106M | 18M | 5.81 | |
| Vir Biotechnology (VIR) | 14.5 | $87M | 8.6M | 10.19 | |
| Biontech Se Sponsored Ads (BNTX) | 13.7 | $83M | 890k | 93.05 | |
| Ideaya Biosciences (IDYA) | 8.3 | $50M | 1.3M | 37.27 | |
| Cytokinetics Com New (CYTK) | 4.8 | $29M | 340k | 85.19 | |
| Lyell Immunopharma Com New (LYEL) | 3.5 | $21M | 1.5M | 14.05 | |
| Spero Therapeutics (SPRO) | 3.4 | $20M | 9.2M | 2.21 | |
| Nkarta (NKTX) | 1.5 | $8.9M | 3.2M | 2.83 | |
| Fulcrum Therapeutics (FULC) | 1.1 | $6.5M | 1.8M | 3.66 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.1 | $6.5M | 1.5M | 4.24 | |
| CVRX (CVRX) | 0.9 | $5.2M | 1.0M | 5.14 | |
| Regenxbio Inc equity us cm (RGNX) | 0.5 | $3.3M | 272k | 11.98 |
